MCT
Selected indexed studies
- Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. (Mol Cancer Ther, 2021) [PMID:33850002]
- ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors. (Mol Cancer Ther, 2022) [PMID:35642431]
- Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. (Mol Cancer Ther, 2016) [PMID:26944918]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma. (2021) pubmed
- ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors. (2022) pubmed
- Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. (2016) pubmed
- Emerging Tumor-Agnostic Molecular Targets. (2024) pubmed
- Discovery of ixabepilone. (2009) pubmed
- Selected Articles from This Issue. (2022) pubmed
- Retraction: Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage. (2024) pubmed
- Predicting the Abscopal Phenomenon-Reply. (2024) pubmed
- microRNA therapies in cancer. (2014) pubmed
- Current Development of Glioblastoma Therapeutic Agents. (2021) pubmed